By artificially stimulating the heart and lungs, cardiopulmonary bypass machines pump oxygen-rich blood to all parts of the body. When the surgeon operates in a bloodless field, it keeps other tissues and organs alive and well. Polyvinyl chloride (PVC) or silicone tubing, a reservoir for holding blood, a bubbler or membrane oxygenator, a cardiotomy (a filtered reservoir), a heat exchanger or two, a filter for the arterial line, a pump or two, a flow metre, an inline blood gas and electrolyte analyzer, and pressure-monitoring devices might all be part of the machine.
The global market for cardiopulmonary bypass equipment is predicted to reach US$ 118.0 Mn in value by 2022, expanding at a CAGR of 1.7% from 2023 to 2030.
Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2026
The prevalence of cardiovascular disease is rising, which will fuel demand for cardiopulmonary bypass devices.
The growth of the cardiopulmonary bypass equipment market is being fueled by a number of factors, including the rising incidence of cardiovascular diseases such as atrial fibrillation, atrial flutter, and supraventricular tachycardia, the age-related decline in cardiac muscle elasticity and output, and the growing elderly population. For example, the American Heart Association reports that between 3 and 6 Mn persons in the United States have atrial fibrillation as of June 2020, with that figure expected to rise to between 6 and 16 Mn by 2050. It is projected that the number of Europeans with atrial fibrillation will rise to 14 Mn by 2060, up from the estimated 12 Mn in 2017. Around 72 Mn Asians will be diagnosed with atrial fibrillation (AF) by 2050, with an additional 3 Mn experiencing a stroke directly attributable to their AF.
Market expansion throughout the forecast period is attributed to an expected rise in the frequency with which organ transplants are performed.
Market expansion throughout the forecast period is attributed to an expected rise in the frequency with which organ transplants are performed. For instance, in 2017, there were approximately 1, 469 organ transplant surgeries, as reported by the Organ and Tissue Authority of Australia’s Government. More than 1,400 people in Australia are on the organ donor waiting list. In addition, as of October 2021, the Australian Government Organ and Tissue Authority reported that 1,750 Australians were on the transplant waiting list. A kidney transplant may be necessary for some of the more than 13,000 patients now undergoing dialysis. According to data provided by the Australian Government Organ and Tissue Authority, 112 heart transplant procedures were done in Australia in 2021.
Global Cardiopulmonary Bypass Equipment Market– Impact of Coronavirus (COVID-19) Pandemic
There has been an outbreak of the COVID-19 virus since December 2019, and on January 30, 2020, the World Health Organization has declared a public health emergency.
There are three primary ways in which COVID-19 can influence the economy: through effects on drug supply and demand, disruptions in distribution networks, and monetary effects on businesses and the financial sector. China, India, Saudi Arabia, the United Arab Emirates, Egypt, and other countries are experiencing difficulties with drug shipments as a result of statewide lockdowns.
Although the global market for cardiopulmonary bypass equipment was otherwise healthy prior to the COVID-19 pandemic, the decline in surgical procedures caused by the virus had a detrimental effect on the market. For example, in February 2022, the National Center for Biotechnology Information reported a significant drop in surgical volume and outpatient medical follow-up due to the COVID-19 pandemic. SARS-CoV-2 is related to surgical procedures. When the chance of exposure to COVID-19 in the hospital increases for surgical patients, they become more vulnerable to the infection after surgery. The number of chronic procedures done was reduced because of the significant risk of developing serious COVID-19 complications as a result of the immunosuppressive response to surgery and the inflammatory cytokine storm associated with COVID-19 infection.
Global Cardiopulmonary Bypass Equipment Market: Key Developments
At the 2022 annual meeting of the International Society for Magnetic Resonance in Medicine, which will take place in May, Koninklijke Philips N.V., a health technology company, will showcase its technological prowess in magnetic resonance imaging for complex diagnostics and rigorous clinical research. During this year’s annual conference of the International Society for Magnetic Resonance in Medicine, Philips debuted a patient-centric MR portfolio enabled by artificial intelligence. Magnetic Resonance (MR) processes can be improved, the staff’s experience can be elevated, and productivity and predictability can be driven by utilising Magnetic Resonance Workspace, which uses AI technology to streamline the process from image acquisition to diagnosis.
Global Cardiopulmonary Bypass Equipment Market: Restraint
The recall of cardiopulmonary bypass equipment components is one of the primary factors restraining expansion of the global cardiopulmonary bypass equipment market. Example: on June 8, 2022, the FDA ordered Medtronic to stop selling its Heart Ware Ventricular Assist Device (HVAD) Pump Implant Kit. According to the FDA, this is a Class I recall because continuing to use the product poses an unreasonable risk of serious adverse health consequences or death. Due to a pump weld issue, Medtronic is issuing a recall for their HVAD Pump Implant Kit. In certain cases, moisture has been able to enter the pump, which has corroded and demagnetized the device’s internal magnets.
Key Players
Some of the most well-known companies in the cardiopulmonary bypass equipment industry are: Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG, Terumo Corporation, Braile Biomedica, and Tianjin Medical.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/2026
| The market size value in 2023 |
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Cardiopulmonary Bypass Equipment Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Cardiopulmonary Bypass Equipment Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Why Choose Coherent Market Insights?
☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.
☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.
☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/2026
Explore More Related Insights:
- Janus Kinase Inhibitor Market
- Disability Devices Market
- U.S. Non-oncology Biopharmaceuticals Market
- P2X7 Receptor Antagonists Market
- Philippines Radiotherapy Market
- Infant Incubator Market
- Hospital Pharmaceuticals Market
- Spirometer Market
- Virginiamycin Market
- Antibodies Market
- Androstenedione Market
- Tourette Syndrome Treatment Market
- Hemorrhoid Treatment Devices Market
- Laboratory Refrigerators and Freezers Market
- Electrocardiogram (ECG) Devices Market
- Surgical Blades Market
- Electrophoresis Market
- Veterinary Radiography Flat Panel Detector Market
- Cardiac Pacing Leads Market
- Biopharmaceutical Stabilization (Lyophilization) Service Market
- Modular Anatomic Reconstruction Market
- Bandages Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837